Total | Anti-RHA (+) | Anti-RHA (-) | |
---|---|---|---|
Number of patients | 62 | 14 | 48 |
RHA | 23% (14/62) | ||
U1RNP | 29% (18/62) | 36% (5/14) | 27% (13/48) |
Sm | 13% (8/62) | 21% (3/14) | 10% (5/48) |
Anti-Sm (+) among anti-U1RNP (+) | 44% (8/18) | 60% (3/5) | 38% (5/13) |
Ribosomal P | 8% (5/62) | 14% (2/14) | 6% (3/48) |
Ro | 39% (24/62) | 29% (4/14) | 42% (20/48) |
La | 8% (5/62) | 0% (0/14) | 10% (5/48) |
Ku | 6% (4/62) | 14% (2/14) | 4% (2/48) |
Su | 24% (15/62) | 29% (4/14) | 23% (11/48) |
RNAP II | 10% (6/62) | 14% (2/14) | 8% (4/48) |